Metabolic Syndrome and Female Breast Cancer

NCT02282592 | Completed

• 1 other identifier: 481.165
• Study Type: observational
• Target: 164
• Locations: 0 countries
• Sites: N/A

Brief Summary

The role among metabolic syndrome and breast cancer risk is not well understood and must be further explored. The objective of this study is to evaluate the association between metabolic syndrome and breast cancer in Southern Brazil. In this case-control study, breast cancer patients and controls without malignant disease, matched for age (±5 years) and menopausal status, were interviewed and asked to make a glucose, HDL-cholesterol and triglycerides test. Waist circumference and blood pressure were measured using standardized procedures. Metabolic Syndrome was considered by NCEP ATP III (2001) and IDF (2006) definitions. Cases and controls were compared in relation to the presence of diagnosed MetS (yes/no), number of metabolic abnormalities identified (1 to 5) for each definition, and according to each metabolic abnormality cutoff point.

Conditions

Breast Cancer

Keywords

Metabolic syndrome; case-control study; Breast cancer

Outcome Measures

Primary Outcomes (1)

• Odds Ratio for Breast Cancer according to the presence of Metabolic Syndrome and its components

  Participants will be evaluated only once before the first appointment with the oncologist (cases with a biopsy) and gynecologist (controls). The blood test results for Metabolic Syndrome parameters were collected in an expected average of 30 days.

Study Arms (2)

Cases

newly diagnosed (within 6 months) breast cancer patients, before adjuvant or neoadjuvant treatment.

Other: Observation about the presence of metabolic syndrome

Controls

patients without any malignant disease, matched for age an menopausal status with cases.

Other: Observation about the presence of metabolic syndrome

Interventions

Observation about the presence of metabolic syndrome OTHER

Cases; Controls

Eligibility Criteria

• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Between December 2013 and August 2014, newly diagnosed (within 6 months) BC female patients referred to the oncology sector of the Teaching Hospital of the Federal University of Pelotas and to the Radiotherapy and Oncology Center of Santa Casa de Misericordia of Pelotas were invited to the study, before starting any adjuvant or neoadjuvant treatment. Women with a recidivated tumor, HIV infection, renal, heart or liver disease, hypothyroidism or hyperthyroidism, mobility or neurological limitations, chronicle use of corticosteroids, pacemakers or identified with severe edema were excluded. For each cancer case, one female control should be matched for age (± 5 years) and menopausal status (pre and post-menopausal). Apart from being free from all the exclusion criteria used for BC cases, controls should also have no signs of malignant disease. These women were invited to participate in the study while frequenting the Gynecologic Ambulatory of the same institutions, in the same period.

You may qualify if:

• For cases: having newly diagnosed breast cancer without adjuvant or neoadjuvant treatment;
• For controls: having no evidence of cancer; be matched for age and menopausal status with controls

You may not qualify if:

• Women with a recidivated tumor, HIV infection, renal, heart or liver disease, hypothyroidism or hyperthyroidism, mobility or neurological limitations, chronicle use of corticosteroids, pacemakers or identified with severe edema were excluded.

Sponsors & Collaborators

• Catholic University of Pelotas: lead

MeSH Terms

Conditions

Breast Neoplasms; Metabolic Syndrome

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Insulin Resistance; Hyperinsulinism; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Master in Health and Behavior

Study Record Dates

• First Submitted: October 17, 2014
• First Posted: November 4, 2014
• Study Start: November 1, 2013
• Primary Completion: August 1, 2014
• Study Completion: October 1, 2014
• Last Updated: November 4, 2014

Record last verified: 2014-10